Search results

Articles (5)

Journals (0)

1-5 of 5 results for CA20948

Sort by:

Relevance

Select all

Sort by:

Relevance

Restricted accessResearch articleFirst published June, 2004

Low-Dose-Rate Irradiation by 131 I Versus High-Dose-Rate External-Beam Irradiation in the Rat Pancreatic Tumor Cell Line CA20948

Suzanne Verwijnen, Astrid Capello, Bert Bernard [...]

Cancer Biotherapy and Radiopharmaceuticals

Free accessResearch articleFirst published January, 2012

Multimodality Imaging of Somatostatin Receptor–Positive Tumors with Nuclear and Bioluminescence Imaging

Stefan E. Pool, Timo L.M. ten Hagen, Stuart Koelewijn [...]

Molecular Imaging

Restricted accessResearch articleFirst published December, 2000

Comparative Dosimetry of Copper-64 and Yttrium-90-Labeled Somatostatin Analogs in a Tumor-Bearing Rat Model

Jason S. Lewis, Richard Laforest, Michael R. Lewis [...]

Cancer Biotherapy and Radiopharmaceuticals

Restricted accessResearch articleFirst published February, 2007

Diagnostic Versus Therapeutic Doses of [ 177 Lu-DOTA-Tyr 3 ]-Octreotate: Uptake and Dosimetry in Somatostatin Receptor-Positive Tumors and Normal Organs

Cristina Müller, Flavio Forrer, Bert F. Bernard [...]

Cancer Biotherapy and Radiopharmaceuticals

Restricted accessResearch articleFirst published October, 2003

Tyr 3 -Octreotide and Tyr 3 -Octreotate Radiolabeled with 177 Lu or 90 Y: Peptide Receptor Radionuclide Therapy Results In Vitro

Astrid Capello, Eric P. Krenning, Wout A.P. Breeman [...]

Cancer Biotherapy and Radiopharmaceuticals

Search results

Articles (5)

Journals (0)

1-5 of 5 results for CA20948

Sort by:

Relevance

Select all

Sort by:

Relevance

Restricted accessResearch articleFirst published June, 2004

Low-Dose-Rate Irradiation by 131 I Versus High-Dose-Rate External-Beam Irradiation in the Rat Pancreatic Tumor Cell Line CA20948

Suzanne Verwijnen, Astrid Capello, Bert Bernard [...]

Cancer Biotherapy and Radiopharmaceuticals

Free accessResearch articleFirst published January, 2012

Multimodality Imaging of Somatostatin Receptor–Positive Tumors with Nuclear and Bioluminescence Imaging

Stefan E. Pool, Timo L.M. ten Hagen, Stuart Koelewijn [...]

Molecular Imaging

Restricted accessResearch articleFirst published December, 2000

Comparative Dosimetry of Copper-64 and Yttrium-90-Labeled Somatostatin Analogs in a Tumor-Bearing Rat Model

Jason S. Lewis, Richard Laforest, Michael R. Lewis [...]

Cancer Biotherapy and Radiopharmaceuticals

Restricted accessResearch articleFirst published February, 2007

Diagnostic Versus Therapeutic Doses of [ 177 Lu-DOTA-Tyr 3 ]-Octreotate: Uptake and Dosimetry in Somatostatin Receptor-Positive Tumors and Normal Organs

Cristina Müller, Flavio Forrer, Bert F. Bernard [...]

Cancer Biotherapy and Radiopharmaceuticals

Restricted accessResearch articleFirst published October, 2003

Tyr 3 -Octreotide and Tyr 3 -Octreotate Radiolabeled with 177 Lu or 90 Y: Peptide Receptor Radionuclide Therapy Results In Vitro

Astrid Capello, Eric P. Krenning, Wout A.P. Breeman [...]

Cancer Biotherapy and Radiopharmaceuticals